Clinical Resources: Standing Orders Templates

Standing Orders for Administering Influenza Vaccine to Adults

Eligible healthcare professionals may vaccinate adults who meet the criteria established in September 2026 by the American Academy of Family Physicians (AAFP), American College of Obstetricians and Gynecologists (ACOG), and Infectious Diseases Society of America (IDSA), and 2026–27 season clinical considerations published by the Centers for Disease Control and Prevention.

#P3074

Updated on: 9/14/26

Language: English

Standing Orders for Administering Nirsevimab RSV Preventive Antibody (Beyfortus, by Sanofi) to Infants and High-Risk Young Children

Eligible healthcare professionals may vaccinate all infants and high-risk young children who meet the criteria established by the American Academy of Pediatrics (AAP) in September 2026 (https://doi.org/10.1542/peds.2026-079047), for immunization with a long-acting preventive antibody against RSV (nirsevimab, brand name Beyfortus, by Sanofi), with information provided on current CDC recommendations.

#P3097

Updated on: 9/14/26

Language: English

Standing Orders for Administering Pfizer Respiratory Syncytial Virus (RSV) Vaccine (Abrysvo) During Pregnancy

Eligible healthcare professionals may vaccinate all pregnant women who meet any of the criteria on this form. This template is consistent with the recommendations of the American College of Obstetricians and Gynecologists.

#P3096

Updated on: 9/14/26

Language: English

Standing Orders for Administering Respiratory Syncytial Virus Vaccine (RSV) to Adults Age 50 Years and Older

Eligible healthcare professionals may vaccinate adults age 50 years and older who meet the criteria established by the CDC’s Advisory Committee on Immunization Practices. These criteria are consistent with the September 2026 recommendations of the American Academy of Family Physicians (AAFP).

#P3098

Updated on: 9/14/26

Language: English

Standing Orders for Administering Clesrovimab RSV Preventive Antibody (Enflonsia, by Merck) to Infants

Eligible healthcare professionals may vaccinate infants younger than 8 months of age who meet the criteria established by the American Academy of Pediatrics (AAP) in September 2026 (https://doi.org/10.1542/peds.2026-079047), for immunization with a long-acting preventive antibody against RSV (clesrovimab, brand name Enflonsia, by Merck).

#P3099

Updated on: 9/13/26

Language: English

Standing Orders for Administering Influenza Vaccine to Children and Teens

Eligible healthcare professionals may vaccinate children and teens who meet any of the criteria on this form

#P3074a

Updated on: 8/14/26

Language: English

Standing Orders for Administering Rotavirus Vaccine to Infants

Eligible healthcare professionals may vaccinate infants who meet any of the criteria on this form. This template is consistent with the American Academy of Pediatrics 2026 Recommended Child and Adolescent Immunization Schedule.

#P3087

Updated on: 5/22/26

Language: English

Checklist of Current Versions of U.S. COVID-19 Vaccination Guidance and Clinic Support Tools

Checklist of links to key COVID-19 vaccination resources, including the date they were last revised.

#P3130

Updated on: 4/28/26

Language: English

Standing Orders for Administering Hepatitis B Vaccine to Children and Teens

Eligible healthcare professionals may vaccinate children and teens who meet any of the criteria on this form. This template is consistent with the American Academy of Pediatrics 2026 Recommended Child and Adolescent Immunization Schedule.

#P3076a

Updated on: 2/16/26

Language: English

Standing Orders for Administering Hepatitis A Vaccine to Children and Teens

Eligible healthcare professionals may vaccinate children and teens who meet any of the criteria on this form. This template is consistent with the American Academy of Pediatrics 2026 Recommended Child and Adolescent Immunization Schedule.

#P3077a

Updated on: 2/16/26

Language: English

Standing Orders for Administering Pneumococcal Vaccines to Children and Teens

Eligible healthcare professionals may vaccinate children or adolescents who meet any of the criteria on this form. This template is consistent with the American Academy of Pediatrics 2026 Recommended Child and Adolescent Immunization Schedule.

#P3086

Updated on: 2/16/26

Language: English

Standing Orders for Administering Meningococcal B Vaccine (MenB) to Adolescents and Adults

Eligible healthcare professionals may vaccinate adolescents and adults who meet any of the criteria on this form. This template is consistent with the American Academy of Pediatrics 2026 Recommended Child and Adolescent Immunization Schedule.

#P3095

Updated on: 2/16/26

Language: English

Standing Orders for Administering Varicella Vaccine to Children and Teens

Eligible healthcare professionals may vaccinate children and teens who meet any of the criteria on this form. This template is consistent with the American Academy of Pediatrics 2026 Recommended Child and Adolescent Immunization Schedule.

#P3080a

Updated on: 2/16/26

Language: English

Standing Orders for Administering Haemophilus influenzae Type B to Children & Teens

Eligible healthcare professionals may vaccinate children and teens who meet any of the criteria on this form. This template is consistent with the American Academy of Pediatrics 2026 Recommended Child and Adolescent Immunization Schedule.

#P3083a

Updated on: 2/16/26

Language: English

Standing Orders for Administering Human Papillomavirus Vaccine to Children and Teens

Eligible healthcare professionals may vaccinate children and teens who meet any of the criteria on this form. This template is consistent with the American Academy of Pediatrics 2026 Recommended Child and Adolescent Immunization Schedule.

#P3090

Updated on: 2/16/26

Language: English

Standing Orders for Administering Tdap During Pregnancy

Eligible healthcare professionals may vaccinate all pregnant women who meet any of the criteria on this form. This template is consistent with recommendations of the American Academy of Pediatrics and the American College of Obstetricians and Gynecologists.

#P3078b

Updated on: 2/16/26

Language: English

Standing Orders for Administering Meningococcal ACWY Vaccine to Children and Teens

Eligible healthcare professionals may vaccinate children and teens who meet any of the criteria on this form. This template is consistent with the American Academy of Pediatrics 2026 Recommended Child and Adolescent Immunization Schedule.

#P3081a

Updated on: 2/16/26

Language: English

Standing Orders for Administering Measles, Mumps, and Rubella Vaccine to Children and Teens

Eligible healthcare professionals may vaccinate children and teens who meet any of the criteria on this form. This template is consistent with the American Academy of Pediatrics 2026 Recommended Child and Adolescent Immunization Schedule.

#P3079a

Updated on: 2/16/26

Language: English

Standing Orders for Administering Tdap/Td Vaccine to Children and Teens Age 7 Years and Older

Eligible healthcare professionals may vaccinate children and teens who meet any of the criteria on this form. This template is consistent with the American Academy of Pediatrics 2026 Recommended Child and Adolescent Immunization Schedule.

#P3078a

Updated on: 2/16/26

Language: English

Standing Orders for Administering Inactivated Poliovirus Vaccine to Infants and Children

Eligible healthcare professionals may vaccinate infants and children who meet any of the criteria on this form. This template is consistent with the American Academy of Pediatrics 2026 Recommended Child and Adolescent Immunization Schedule.

#P3071

Updated on: 2/16/26

Language: English

Standing Orders for Administering Diphtheria, Tetanus, and Acellular Pertussis (DTaP) Vaccine to Children Younger Than Age 7 Years

Eligible healthcare professionals may vaccinate children under 7 who meet any of the criteria on this form. This template is consistent with the American Academy of Pediatrics 2026 Recommended Child and Adolescent Immunization Schedule.

#P3073

Updated on: 2/9/26

Language: English

Standing Orders for Administering 2025-2026 Formula Adjuvanted Protein COVID-19 Vaccine to Individuals 12 Years and Older

Eligible healthcare professionals may administer Nuvaxovid (Sanofi-Novavax) COVID-19 vaccine to individuals 12 years of age and older, following clinical guidance from CDC (Interim Clinical Considerations for Use of COVID-19 Vaccines). A list of high-risk conditions supported by evidence is provided, along with a list of conditions that should trigger use of the dosing schedule for people with moderate or severe immunocompromise. CDC recommends COVID-19 vaccination of any person age 6 months or older following a shared clinical decision-making discussion. Links to current COVID-19 vaccine recommendations from AAP, AAFP, IDSA, and ACOG are also provided. These organizations recommend routine vaccination for designated people at increased risk of infection or severe disease and shared clinical decision-making for those at lower risk.

#P3141

Updated on: 11/13/25

Language: English

Standing Orders for Administering 2025-2026 Formula mRNA COVID-19 Vaccine to Children 6 Months through 11 Years

Eligible healthcare professionals may administer mRNA COVID-19 vaccines to children 6 months through 11 years, following clinical guidance from CDC (Interim Clinical Considerations for Use of COVID-19 Vaccines). A list of high-risk conditions supported by evidence is provided, along with a list of conditions that should trigger use of the dosing schedule for people with moderate or severe immunocompromise. CDC recommends COVID-19 vaccination of any person age 6 months or older following a shared clinical decision-making discussion. Links to current COVID-19 vaccine recommendations from AAP, AAFP, and IDSA are also provided. These organizations recommend routine vaccination for designated people at increased risk of infection or severe disease and shared clinical decision-making for those at lower risk.

#P3140a

Updated on: 11/13/25

Language: English

Standing Orders for Administering 2025-2026 Formula mRNA COVID-19 Vaccine to Individuals 12 Years and Older

Eligible healthcare professionals may administer mRNA COVID-19 vaccines to individuals 12 years of age and older, following clinical guidance from CDC (Interim Clinical Considerations for Use of COVID-19 Vaccines). A list of high-risk conditions supported by evidence is provided, along with a list of conditions that should trigger use of the dosing schedule for people with moderate or severe immunocompromise. CDC recommends COVID-19 vaccination of any person age 6 months or older following a shared clinical decision-making discussion. Links to current COVID-19 vaccine recommendations from AAP, AAFP, IDSA, and ACOG are also provided. These organizations recommend routine vaccination for designated people at increased risk of infection or severe disease and shared clinical decision-making for those at lower risk.

#P3140

Updated on: 11/13/25

Language: English